Stay updated on Dupilumab in COPD Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in COPD Clinical Trial page.

Latest updates to the Dupilumab in COPD Clinical Trial page
- CheckyesterdayChange DetectedLocation labels were updated to standardize how certain site and region names are displayed (Chile and Turkey), and the page revision/version string was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded a new publication entry: Win Ratio Analysis to Clarify Clinical Benefits: A Post Hoc Analysis of Phase 3 BOREAS and NOTUS. Chest. 2026 Mar 5: online ahead of print.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page revision was updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded Revision: v3.4.1 and removed prior notices: the lapse in government funding notice and Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Dupilumab in COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in COPD Clinical Trial page.